ZEN Graphene Solutions Ltd (ZTEK) - Net Assets
Based on the latest financial reports, ZEN Graphene Solutions Ltd (ZTEK) has net assets worth $11.69 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($16.87 Million) and total liabilities ($5.18 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check ZTEK asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $11.69 Million |
| % of Total Assets | 69.27% |
| Annual Growth Rate | 11.1% |
| 5-Year Change | -46.29% |
| 10-Year Change | -31.25% |
| Growth Volatility | 68.98 |
ZEN Graphene Solutions Ltd - Net Assets Trend (2010–2025)
This chart illustrates how ZEN Graphene Solutions Ltd's net assets have evolved over time, based on quarterly financial data. Also explore ZEN Graphene Solutions Ltd assets under control for the complete picture of this company's asset base.
Annual Net Assets for ZEN Graphene Solutions Ltd (2010–2025)
The table below shows the annual net assets of ZEN Graphene Solutions Ltd from 2010 to 2025. For live valuation and market cap data, see market cap of ZEN Graphene Solutions Ltd.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | $14.75 Million | -0.96% |
| 2024-03-31 | $14.89 Million | -50.99% |
| 2023-03-31 | $30.38 Million | -8.50% |
| 2022-03-31 | $33.21 Million | +20.91% |
| 2021-03-31 | $27.46 Million | +6.81% |
| 2020-03-31 | $25.71 Million | +3.28% |
| 2019-03-31 | $24.90 Million | +12.79% |
| 2018-03-31 | $22.07 Million | -2.82% |
| 2017-03-31 | $22.71 Million | +5.87% |
| 2016-03-31 | $21.45 Million | +5.08% |
| 2015-03-31 | $20.42 Million | -2.88% |
| 2014-03-31 | $21.02 Million | +27.81% |
| 2013-03-31 | $16.45 Million | +60.82% |
| 2012-03-31 | $10.23 Million | -8.18% |
| 2011-03-31 | $11.14 Million | +266.30% |
| 2010-03-31 | $3.04 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to ZEN Graphene Solutions Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 8370517000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $89.48 Million | 606.65% |
| Other Components | $9.13 Million | 61.87% |
| Total Equity | $14.75 Million | 100.00% |
ZEN Graphene Solutions Ltd Competitors by Market Cap
The table below lists competitors of ZEN Graphene Solutions Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ImmuCell Corporation
NASDAQ:ICCC
|
$54.73 Million |
|
PDS Biotechnology Corp
NASDAQ:PDSB
|
$54.76 Million |
|
Falcon Machine Tools Co Ltd
TWO:4513
|
$54.77 Million |
|
biote Corp
NASDAQ:BTMD
|
$54.78 Million |
|
Shinih Enterprise Co Ltd
TW:9944
|
$54.72 Million |
|
Tunas Alfin Tbk
JK:TALF
|
$54.72 Million |
|
Sonel S.A.
WAR:SON
|
$54.71 Million |
|
IBKS No2 SPAC
KQ:204840
|
$54.68 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ZEN Graphene Solutions Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 14,891,864 to 14,749,447, a change of -142,417 (-1.0%).
- Net loss of 10,039,658 reduced equity.
- New share issuances of 3,069,950 increased equity.
- Other comprehensive income decreased equity by 7,890,493.
- Other factors increased equity by 14,717,784.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-10.04 Million | -68.07% |
| Share Issuances | $3.07 Million | +20.81% |
| Other Comprehensive Income | $-7.89 Million | -53.5% |
| Other Changes | $14.72 Million | +99.79% |
| Total Change | $- | -0.96% |
Book Value vs Market Value Analysis
This analysis compares ZEN Graphene Solutions Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.56x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 3.74x to 3.56x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2010-03-31 | $0.14 | $0.51 | x |
| 2011-03-31 | $0.40 | $0.51 | x |
| 2012-03-31 | $0.26 | $0.51 | x |
| 2013-03-31 | $0.40 | $0.51 | x |
| 2014-03-31 | $0.39 | $0.51 | x |
| 2015-03-31 | $0.36 | $0.51 | x |
| 2016-03-31 | $0.37 | $0.51 | x |
| 2017-03-31 | $0.37 | $0.51 | x |
| 2018-03-31 | $0.35 | $0.51 | x |
| 2019-03-31 | $0.37 | $0.51 | x |
| 2020-03-31 | $0.33 | $0.51 | x |
| 2021-03-31 | $0.33 | $0.51 | x |
| 2022-03-31 | $0.36 | $0.51 | x |
| 2023-03-31 | $0.31 | $0.51 | x |
| 2024-03-31 | $0.15 | $0.51 | x |
| 2025-03-31 | $0.14 | $0.51 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ZEN Graphene Solutions Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -68.07%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1150.68%
- • Asset Turnover: 0.05x
- • Equity Multiplier: 1.25x
- Recent ROE (-68.07%) is below the historical average (-26.80%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2010 | -4.87% | 0.00% | 0.00x | 1.05x | $-452.02K |
| 2011 | -11.15% | 0.00% | 0.00x | 1.09x | $-2.36 Million |
| 2012 | -10.16% | 0.00% | 0.00x | 1.10x | $-2.06 Million |
| 2013 | -14.30% | 0.00% | 0.00x | 1.03x | $-4.00 Million |
| 2014 | -16.77% | 0.00% | 0.00x | 1.01x | $-5.63 Million |
| 2015 | -14.77% | 0.00% | 0.00x | 1.01x | $-5.06 Million |
| 2016 | -19.57% | 0.00% | 0.00x | 1.00x | $-6.34 Million |
| 2017 | -12.51% | 0.00% | 0.00x | 1.00x | $-5.11 Million |
| 2018 | -7.09% | 0.00% | 0.00x | 1.01x | $-3.77 Million |
| 2019 | -9.75% | 0.00% | 0.00x | 1.03x | $-4.92 Million |
| 2020 | -4.21% | 0.00% | 0.00x | 1.02x | $-3.65 Million |
| 2021 | -14.09% | -164273.89% | 0.00x | 1.10x | $-6.61 Million |
| 2022 | -95.45% | -9330.95% | 0.01x | 1.08x | $-35.01 Million |
| 2023 | -47.44% | -19784.87% | 0.00x | 1.10x | $-17.45 Million |
| 2024 | -78.59% | -39254.06% | 0.00x | 1.12x | $-13.19 Million |
| 2025 | -68.07% | -1150.68% | 0.05x | 1.25x | $-11.51 Million |
Industry Comparison
This section compares ZEN Graphene Solutions Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,863,507,886
- Average return on equity (ROE) among peers: -17.76%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ZEN Graphene Solutions Ltd (ZTEK) | $11.69 Million | -4.87% | 0.44x | $54.73 Million |
| Akoya Biosciences Inc (AKYA) | $121.35 Million | -35.38% | 0.57x | $64.44 Million |
| Align Technology Inc (ALGN) | $1.35 Billion | 32.89% | 0.86x | $12.66 Billion |
| AngioDynamics Inc (ANGO) | $517.03 Million | -1.36% | 0.37x | $444.32 Million |
| AptarGroup Inc (ATR) | $2.71 Billion | 14.48% | 0.94x | $7.66 Billion |
| AtriCure Inc (ATRC) | $16.74 Million | -22.66% | 1.01x | $1.44 Billion |
| Avinger Inc (AVGR) | $-73.64 Million | 0.00% | 0.00x | $1.52 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $10.52 Million | -163.15% | 1.04x | $156.14 Million |
| Avantor Inc (AVTR) | $5.57 Billion | -9.53% | 1.12x | $5.43 Billion |
| Azenta Inc (AZTA) | $553.69 Million | -12.55% | 0.24x | $1.04 Billion |
| Baxter International Inc (BAX) | $7.87 Billion | 19.65% | 1.00x | $8.85 Billion |
About ZEN Graphene Solutions Ltd
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coatings under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It also… Read more